FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Ketamine Injection
Status: Currently in Shortage
»Date first posted: 02/16/2018
»Therapeutic Categories: Anesthesia

Expand all

Eugia Pharma Specialties LTD. (formerly Aurobindo) (Revised 01/07/2022)

Company Contact Information:
888-238-7880

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
200 mg / 20 mL (NDC 67457-181-20) Currently on backorder, next shipment anticipated mid January Mylan label; Sporadic availability expected.
500 mg / 10 mL (NDC 67457-001-10) Available Check wholesalers for inventory
1000 mg / 10 mL (NDC 67457-108-10) Currently on backorder, next shipment TBD Mylan label; Sporadic availability expected.

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 01/13/2022)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50 mg/mL, 10 mL vial (NDC 0143-9508-10) Inventory is currently available. Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released. Demand increase for the drug
100 mg/mL, 5 mL vial (NDC 0143-9509-10) This presentation is temporarily on backorder. Additional lots are scheduled for manufacturing and will be available in the January - February 2022 timeframe. Product will be made available as it is released.

Hospira, Inc. (Reverified 01/05/2022)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg/5 mL (100 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2051-05) Limited Supply Available. Next Delivery: May 2022; Estimated Recovery: September 2022 Demand increase for the drug
500 mg/10 mL (50 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2053-10) Next Delivery and Estimated Recovery: February 2023 Demand increase for the drug

Par Pharmaceutical (Revised 07/07/2021)

Company Contact Information:
201-802-4000

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mg/mL, 20 mL MDV (NDC 42023-113-10) Product Available – Please Check Wholesalers for Availability
100 mg/mL, 5 mL MDV (NDC 42023-115-10) Product Available – Please Check Wholesalers for Availability
50 mg/mL, 10 mL MDV (NDC 42023-114-10) Product Available – Please Check Wholesalers for Availability Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English